BioSpace News Archive

REGENXBIO Inc., a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, announced it will present at the following December investor conferences, which will each be held in a virtual meeting format:

Taiho Oncology, Inc. today announced that the FDA approved hypomethylating agent INQOVI® (decitabine and cedazuridine) 35 mg/100 mg tablets, for oral use, has been included in the latest National Comprehensive Cancer Network® Clinical Practice Guidelines (NCCN Guidelines®) in Oncology for Myelodysplastic Syndromes (MDS).

MouthWatch, LLC, a leader in innovative teledentistry solutions, digital case presentation tools and intraoral imaging devices, recently published a highly relevant whitepaper entitled, “Teledentistry: Post-COVID-19 Use for Safe, Efficient and Evidence-Based Care.”

VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, announced today it has launched its VitalPatch RTM cardiac monitoring solution for patients who require extended Holter monitoring.

Merck Animal Health, known as MSD Animal Health outside the US and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA, announced a new survey about first-time dog owners and whether or not they were prepared for pet parenthood.

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, will participate in discussions at the Piper Sandler 32nd Annual Virtual Healthcare Conference taking place November 30 – December 3. A pre-recorded discussion with LivaNova and Piper Sandler will be available

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2020 Evercore ISI HealthCONx Conference on December 1.

Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced today the launch of its Active Intelligence® platform of technologies that spans the entire journey of patient care

Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer will be participating in the Piper Sandler 32nd Annual Virtual Healthcare Conference

Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer pre-recorded a fireside chat on Tuesday, November 17, 2020. To register for access to the pre-recorded fireside chat, go to the Events & Presentations section of the Company’s Investor Relations w